Skip to main content
Year archive

European Medical Solutions — 2018 filings

All 146 regulatory filings released by European Medical Solutions (ALEMS) in 2018, sourced directly from the official regulator.

146 Filings
2018 Period
2018 filings (146)
Filing Released Lang
ASIT BioTech - expédition acte 17.12.2018.pdf
AGM Information
2018-12-19 French
Summary of the Shareholders’ Meeting of December 17, 2018 and the Board Meeting of December 18, 2018
Board/Management Information
2018-12-19 English
Compte rendu de l’Assemblée générale du 17 décembre 2018 et du Conseil d’administration du 18 décembre 2018
AGM Information
2018-12-19 French
Communicated under the obligation to provide permanent information / Other communications
AGM Information
2018-12-19 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
AGM Information
2018-12-19 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings
2018-12-17 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings
2018-12-17 English
Communicated under the obligation to provide permanent information / Other communications
Declaration of Voting Results & Voting Rights Announcements
2018-12-06 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Declaration of Voting Results & Voting Rights Announcements
2018-12-06 French
20181206_Nombre_Actions_ASIT_ENG.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-12-06 English
20181206_Nombre_Actions_ASIT_FR.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-12-06 French
20181203_Transparency_information_EN_vf.pdf
Major Shareholding Notification
2018-12-03 English
20181203_Transparency_information_FR_vf.pdf
Director's Dealing
2018-12-03 French
Communicated under the obligation to provide permanent information / Other communications
Major Shareholding Notification
2018-12-03 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Declaration of Voting Results & Voting Rights Announcements
2018-12-03 French
20181129_Nombre_Actions_ASIT_ENG_01308.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-11-29 English
20181129_Nombre_Actions_ASIT_FR_d2802.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-11-29 French
Information relating to the total number of voting rights and shares making up the capital
Share Issue/Capital Change
2018-11-29 English
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change
2018-11-29 French
Communicated under the obligation to provide permanent information / Other communications
Report Publication Announcement
2018-11-28 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings
2018-11-28 French
ASIT AGEX 17 décembre 2018 Procuration FR V3.pdf
Proxy Solicitation & Information Statement
2018-11-28 French
Appendix 2 - ASIT AGEX 17 December 2018 - Rights of shareholders.pdf
Proxy Solicitation & Information Statement
2018-11-28 English
Annexe 3 - ASIT AGEX 17 décembre 2018 - Rapport 604 CS.pdf
Capital/Financing Update
2018-11-28 French
ASIT AGEX 17 décembre 2018 Procuration ENG v3.pdf
Proxy Solicitation & Information Statement
2018-11-28 English
Annexe 2 - ASIT AGEX 17 décembre 2018 - Droits des actionnaires FR.pdf
Proxy Solicitation & Information Statement
2018-11-28 French
ASIT AGEX 17 décembre 2018 - Convocation ENG V3.pdf
AGM Information
2018-11-28 English
ASIT AGEX 17 décembre 2018 - Convocation FR V3.pdf
AGM Information
2018-11-28 French
Communicated under the obligation to provide permanent information / Other communications
Earnings Release H2 2019
2018-11-26 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings
2018-11-26 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings
2018-11-19 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings
2018-11-19 English
Document availability communications / Preparatory documents for the general meeting
AGM Information
2018-11-16 English
Communiqués de mise à disposition de documents / Modalités de mise à disposition des documents préparatoires à l'AG
AGM Information
2018-11-16 French
20181114_Transparency_information_EN_53253.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-11-14 English
20181114_Transparency_information_FR_3339b.pdf
Director's Dealing
2018-11-14 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Major Shareholding Notification
2018-11-14 French
Communicated under the obligation to provide permanent information / Other communications
Declaration of Voting Results & Voting Rights Announcements
2018-11-14 English
20181108_Nombre_Actions_ASIT_ENG_vf.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-11-08 English
20181108_Nombre_Actions_ASIT_FR_vf.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-11-08 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings
2018-11-05 English
20181004_Transparency_information_EN.pdf
Major Shareholding Notification
2018-10-04 English
20181004_Transparency_information_FR.pdf
Major Shareholding Notification
2018-10-04 French
20181004_Nombre_Actions_ASIT_ENG.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-10-04 English
20181004_Nombre_Actions_ASIT_FR.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-10-04 French
20180928_Transparency_information_EN.pdf
Major Shareholding Notification
2018-09-28 English
20180928_Transparency_information_FR.pdf
Major Shareholding Notification
2018-09-28 French
ASIT biotech presents its 2018 half-year results and provides an update on its clinical programs until end-2019
Interim / Quarterly Report H1 2018
2018-09-19 English
ASIT biotech présente ses résultats semestriels 2018 et fait un point d'étape sur ses programmes cliniques jusqu'à fin 2019
Interim / Quarterly Report H1 2018
2018-09-19 French
ASIT biotech stelt zijn halfjaarresultaten 2018 voor en geeft een update over zijn klinische programma's tot eind 2019
Interim / Quarterly Report H1 2018
2018-09-19 Dutch
ASITBiotech_RFS_2018.pdf
Interim / Quarterly Report H1 2018
2018-09-19 French
ASITBiotech_HYreport2018.pdf
Interim / Quarterly Report H1 2018
2018-09-19 English
20180906_Numbers_Shares_ASIT_ENG.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-09-06 English
20180906_Nombre_Actions_ASIT_FR.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-09-06 French
20180802_Numbers_Shares_ASIT_ENG.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-08-02 English
20180802_Nombre_Actions_ASIT_FR.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-08-02 French
ASIT - Rapport CA 603 583 596 Signé 10.07.2018.pdf
Capital/Financing Update
2018-07-16 French
20180713_Numbers_Shares_ASIT_ENG.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-07-13 English
20180713_Nombre_Actions_ASIT_FR.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-07-13 French
ASIT Biotech Raises €12 Million of Commitments in a Convertible Bond Private Placement that was Heavily Oversubscribed
Capital/Financing Update
2018-07-11 English
ASIT biotech collecte 12 M€ d’engagements dans le cadre d’un placement privé d’obligations convertibles qui a été largement sursouscrit
Capital/Financing Update
2018-07-11 French
ASIT biotech Announces Private Placement of Convertible Bonds
Capital/Financing Update
2018-07-10 English
ASIT biotech annonce un placement privé sous forme d’obligations convertibles
Capital/Financing Update
2018-07-10 French
20180704_Numbers_Shares_ASIT_ENG.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-07-04 English
20180704_Nombre_Actions_ASIT_FR.pdf
Share Issue/Capital Change
2018-07-04 French
ASIT biotech selects a new product candidate hdm-ASIT+™ for the high-potential market for treating house dust mite allergy
Regulatory Filings
2018-06-25 English
ASIT biotech sélectionne un nouveau produit candidat hdm-ASIT+™ pour le marché à fort potentiel du traitement de l‘allergie aux acariens
Regulatory Filings
2018-06-25 French
ASIT biotech selecteert een nieuw kandidaat-product hdm-ASIT+™ voor de potentieel grote markt voor de behandeling van huisstofmijtallergie
Regulatory Filings
2018-06-25 Dutch
20180615 Rapport spécial CA art 583 596 598.pdf
Share Issue/Capital Change
2018-06-19 French
20180614 PV AGO ENG signé.pdf
AGM Information
2018-06-19 English
20180614 PV AGO FR signé.pdf
AGM Information
2018-06-19 French
20180618_Numbers_Shares_ASIT_ENG.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-06-18 English
20180618_Nombre_Actions_ASIT_FR.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-06-18 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Capital/Financing Update
2018-06-18 French
Information relating to the total number of voting rights and shares making up the capital
Share Issue/Capital Change
2018-06-18 English
ASIT biotech selects a first ASIT+™ product candidate for the development of a treatment for peanut allergy
Regulatory Filings
2018-06-11 English
ASIT biotech sélectionne un premier produit candidat ASIT+™ pour le développement d’un traitement pour l’allergie à l’arachide
Regulatory Filings
2018-06-11 French
ASIT biotech selecteert een eerste kandidaat-product ASIT+™ voor de ontwikkeling van een behandeling tegen pinda-allergie
Regulatory Filings
2018-06-11 Dutch
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings
2018-06-11 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings
2018-06-11 French
Communicated under the obligation to provide permanent information / Other communications
Report Publication Announcement
2018-05-30 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Report Publication Announcement
2018-05-30 French
Communiqués de mise à disposition de documents / Modalités de mise à disposition des documents préparatoires à l'AG
Report Publication Announcement
2018-05-16 French
Document availability communications / Preparatory documents for the general meeting
AGM Information
2018-05-16 English
Annexe 3 - ASIT AGO 2018 - Rapport annuel 2017 incluant le rapport de gestion.pdf
Annual Report FY 2017
2018-05-15 French
Annexe 6 - ASIT AGO 2018 - Comptes annuels statutaires 2017.pdf
Annual Report FY 2017
2018-05-15 French
Annexe 4 - ASIT AGO 2018 - Rapport du commissaire sur les comptes annuels 2017.pdf
Audit Report / Information FY 2017
2018-05-15 French
Annexe 8 - ASIT AGO 2018 - CV Harry Welten en anglais.pdf
Board/Management Information
2018-05-15 French
Annexe 1 - ASIT AGO 2018 - Procuration.pdf
Proxy Solicitation & Information Statement
2018-05-15 French
Annexe 5 - ASIT AGO 2018 - Rapport du commissaire sur les états financier consolidés 2017.pdf
Audit Report / Information FY 2017
2018-05-15 French
Annexe 7 - ASIT AGO 2018 - Plan de warrants 2018.pdf
Capital/Financing Update
2018-05-15 French
Annexe 2 - ASIT AGO 2018 - Droits des actionnaires.pdf
AGM Information
2018-05-15 French
ASIT AGM 2018 - Invitation to the AGM of June 14, 2018 ENG.pdf
AGM Information
2018-05-15 English
ASIT AGO 2018 - Convocation à l'AGO du 14 juin 2018 FR.pdf
AGM Information
2018-05-15 French
20180502 CP_ASIT_Plateforme_ex_vivo_FR_final.pdf
Regulatory Filings
2018-05-02 French
20180502 PB_ASIT_Plateforme ex vivo_NL_final.pdf
Regulatory Filings
2018-05-02 Dutch
ASIT biotech identifies an original mechanism of action for gp-ASIT+™ that is the basis for a new method for the in vitro selection of future ASIT+™ products for allergen immunotherapy
Regulatory Filings
2018-05-02 English
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings
2018-05-02 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings
2018-05-02 French
ASIT BIOTECH - ANNUAL REPORT 2017 - v 16042018 (2).pdf
Annual Report FY 2017
2018-04-18 English
ASIT Rapport annuel 2017 FR FINAL.pdf
Annual Report FY 2017
2018-04-18 French
Annual financial report
Annual Report FY 2017
2018-04-18 English
ASIT biotech announces the publication of its 2017 annual financial report
Report Publication Announcement
2018-04-18 English
ASIT biotech annonce la publication de son rapport financier annuel 2017
Report Publication Announcement
2018-04-18 French
20180418 ASIT_PR_RFA_public_2017_EN.pdf
Report Publication Announcement
2018-04-18 English
20180418 ASIT_CP_RFA_public_2017_FR.pdf
Report Publication Announcement
2018-04-18 French
Communiqués de mise à disposition de documents / Modalités de mise à disposition du rapport financier annuel
Report Publication Announcement
2018-04-18 French
Document availability communications / Annual financial report
Report Publication Announcement
2018-04-18 English
Communicated under the obligation to provide permanent information / Other communications
Declaration of Voting Results & Voting Rights Announcements
2018-03-19 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Declaration of Voting Results & Voting Rights Announcements
2018-03-19 French
20180319_Nombre_Actions_ASIT_FR_vf.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-03-19 French
20180319_Numbers_Shares_ASIT_ENG_vf.pdf
Share Issue/Capital Change
2018-03-19 English
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings
2018-03-12 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings
2018-03-12 French
20180227_Numbers_Shares_ASIT_ENG.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-02-27 English
20180227_Nombre_Actions_ASIT_FR.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-02-27 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change
2018-02-27 French
Information relating to the total number of voting rights and shares making up the capital
Share Issue/Capital Change
2018-02-27 English
ASIT biotech successfully completes the second tranche of its capital increase, reaching a total amount raised of €13.9 million
Capital/Financing Update
2018-02-23 English
ASIT biotech clôture avec succès la seconde tranche de son augmentation de capital et porte le montant total levé à 13,9 M€
Capital/Financing Update
2018-02-23 French
ASIT biotech sluit de tweede schijf van zijn kapitaalverhoging met succes af en brengt het totale opgehaalde bedrag op 13,9 miljoen euro
Share Issue/Capital Change
2018-02-23 Dutch
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Capital/Financing Update
2018-02-23 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Capital/Financing Update
2018-02-23 French
Communicated under the obligation to provide permanent information / Other communications
Major Shareholding Notification
2018-02-12 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Major Shareholding Notification
2018-02-12 French
20180212_Transparency_information_EN.pdf
Major Shareholding Notification
2018-02-12 English
20180209_Transparency_information_FR.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-02-12 French
ASIT biotech 2017 Annual Results: ongoing ASIT+™ products development in respiratory and food allergies
Capital/Financing Update
2018-02-12 English
Résultats annuels 2017 d’ASIT biotech : poursuite du développement des produits ASIT+™ dans les allergies respiratoires et alimentaires
Earnings Release FY 2017
2018-02-12 French
Jaarresultaten 2017 ASIT biotech: verdere ontwikkeling van ASIT+™-producten in ademhalings- en voedselallergieën
Capital/Financing Update
2018-02-12 Dutch
20180130_Transparency_information_EN.pdf
Major Shareholding Notification
2018-01-30 English
20180130_Transparency_information_FR.pdf
Director's Dealing
2018-01-30 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Major Shareholding Notification
2018-01-30 French
Communicated under the obligation to provide permanent information / Other communications
Major Shareholding Notification
2018-01-30 English
20180129_Numbers_Shares_ASIT_ENG.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-01-29 English
20180129_Nombre_Actions_ASIT_FR.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-01-29 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Capital/Financing Update
2018-01-29 French
Information relating to the total number of voting rights and shares making up the capital
Share Issue/Capital Change
2018-01-29 English
Communicated under the obligation to provide permanent information / Other communications
Share Issue/Capital Change
2018-01-25 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Share Issue/Capital Change
2018-01-25 French
20180125 ASIT PV AGE.pdf
Capital/Financing Update
2018-01-25 French
ASIT biotech successfully completes the first tranche of its capital increase and raises €9.4 million
Share Issue/Capital Change
2018-01-25 English
ASIT biotech clôture avec succès la première tranche de son augmentation de capital et lève 9,4 M€
Share Issue/Capital Change
2018-01-25 French
ASIT biotech sluit succesvol de eerste schijf van zijn kapitaalverhoging af en haalt 9,4 miljoenen euro op
Share Issue/Capital Change
2018-01-25 Dutch
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings
2018-01-11 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings
2018-01-11 French